Profile
| Metric | Value |
|---|---|
| Full Name | Revelation Biosciences, Inc. |
| Ticker | NASDAQ: REVB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | revbiosciences.com |
| Employees | 8 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.90 | |
| Price, 1D Change | -1.11% | |
| $5M | ||
| - | ||
| - | ||
| 0.19 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$263.05 | ||
| EPS, 1Y Change | -49,918.94% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:3 | |
| Next Split | N/A | N/A |
| Last Ticker Change | PAIC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$263.05 | ||
| EPS Estimate | -$9.15 | |
| EPS Est. Change | +96.52% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $0.90 | |
| Price Target | - | $21.25 |
| Price Tgt. Change | - | +2,260.59% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $15.27 | -$0.53 | -103.44% | |
| -$119.68 | -$263.05 | -119.79% | |
| -$9.15 | N/A | +96.52% | |
| -$3.58 | N/A | +98.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.90 | |
| $3.38 | ||
| SMA 200 vs Price | +275.83% | |
| $0.97 | ||
| SMA 50 vs Price | +7.78% | |
| 0.19 | ||
| $0.07 | ||
| 46.84 | ||
| 67.28% | ||
| 109.95% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$263.05 | ||
| -$27.90K | ||
| - | ||
| -$7.98M | ||
| - | ||
| -$15.04M | ||
| - | ||
| -$7.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.43 | ||
| 3.43 | ||
| - | ||
| - | ||
| -10.02 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.48 | ||
| 0.90 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $14.13M | ||
| $6.50M | ||
| $6.62M | ||
| $6.57M | ||
| $1.91M | ||
| $1.91M | ||
| $0.00 | ||
| $0.00 | ||
| $783.60K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $15.04M | ||
| $7.95M | ||
| $27.90K | ||
| $0.00 | ||
| $27.90K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$18.32M | ||
| -$19.20K | ||
| $12.85M | ||
| $19.20K | ||
| -$18.34M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Roth MKM | ||
| Roth Capital |
Analyst sentiment
Institutional ownership
Screeners with REVB
Data Sources & References
- REVB Official Website www.revbiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1810560/000119312525269450/0001193125-25-269450-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1810560/000095017025034584/0000950170-25-034584-index.htm
- REVB Profile on Yahoo Finance finance.yahoo.com/quote/REVB
- REVB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/revb
FAQ
What is the ticker symbol for Revelation Biosciences, Inc.?
The ticker symbol for Revelation Biosciences, Inc. is NASDAQ:REVB
Does Revelation Biosciences, Inc. pay dividends?
No, Revelation Biosciences, Inc. does not pay dividends
What sector is Revelation Biosciences, Inc. in?
Revelation Biosciences, Inc. is in the Healthcare sector
What industry is Revelation Biosciences, Inc. in?
Revelation Biosciences, Inc. is in the Biotechnology industry
What country is Revelation Biosciences, Inc. based in?
Revelation Biosciences, Inc. is headquartered in United States
When did Revelation Biosciences, Inc. go public?
Revelation Biosciences, Inc. initial public offering (IPO) was on November 17, 2020
Is Revelation Biosciences, Inc. in the S&P 500?
No, Revelation Biosciences, Inc. is not included in the S&P 500 index
Is Revelation Biosciences, Inc. in the NASDAQ 100?
No, Revelation Biosciences, Inc. is not included in the NASDAQ 100 index
Is Revelation Biosciences, Inc. in the Dow Jones?
No, Revelation Biosciences, Inc. is not included in the Dow Jones index
When was Revelation Biosciences, Inc. last earnings report?
Revelation Biosciences, Inc.'s most recent earnings report was on November 6, 2025
When does Revelation Biosciences, Inc. report earnings?
The next expected earnings date for Revelation Biosciences, Inc. is March 5, 2026